Table 2.
Pearson partial correlation analysis between NLR, PLR, MPVLR, MLR, CRP, VAS, BASFI and BASDAI scores in ankylosing spondylitis patients
| Before ozone therapy | After ozone therapy | |||||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|||||||
| CRP | VAS | BASFI | BASDAI | CRP | VAS | BASFI | BASDAI | |
| Neutrophil/lymphocyte ratio | ||||||||
| r | 0.697 | 0.482 | 0.465 | 0.655 | 0.307 | 0.294 | 0.025 | 0.216 |
| 95% confidence interval | 0.461–0.839 | 0.295–0.613 | 0.289–0.621 | 0.496–0.758 | 0.025–0.575 | 0.051–0.503 | –0.218–0.303 | –0.100–0.470 |
| P | < 0.001 | < 0.001 | < 0.001 | < 0.001 | 0.025 | 0.033 | 0.858 | 0.121 |
| Platelet/lymphocyte ratio | ||||||||
| r | 0.583 | 0.335 | 0.226 | 0.382 | 0.644 | 0.399 | –0.063 | 0.104 |
| 95% confidence interval | 0.285–0.759 | 0.140–0.508 | –0.066–0.460 | 0.135–0.573 | 0.392–0.806 | 0.176–0.610 | –0.284–0.220 | –0.155–0.389 |
| P | < 0.001 | 0.014 | 0.103 | 0.005 | < 0.001 | 0.003 | 0.651 | 0.459 |
| Mean platelet volume/lymphocyte ratio | ||||||||
| r | 0.286 | 0.351 | 0.075 | 0.04 | 0.02 | 0.166 | 0.042 | 0.099 |
| 95% confidence interval | 0.058–0.500 | 0.127–0.558 | –0.180–0.332 | –0.212–0.290 | –0.369–0.423 | –0.117–0.472 | –0.216–0.304 | –0.121–0.315 |
| P | 0.038 | 0.01 | 0.592 | 0.778 | 0.888 | 0.236 | 0.766 | 0.479 |
| Monocyte/lymphocyte ratio | ||||||||
| r | 0.361 | 0.206 | 0.118 | 0.056 | 0.565 | 0.251 | –0.238 | –0.101 |
| 95% confidence interval | –0.028–0.634 | –0.014–0.421 | –0.099–0.360 | –0.230–0.325 | 0.177–0.830 | 0.046–0.450 | –0.409 to –0.024 | –0.222–0.000 |
| P | 0.008 | 0.139 | 0.402 | 0.691 | < 0.001 | 0.07 | 0.086 | 0.474 |
Note: BASDAI: Bath Ankylosing Spondylitis Disease Activity Index; BASFI: Bath Ankylosing Spondylitis Functional Index; CRP: C-reactive protein; VAS: Visual Analog Scale.